Table 2

Differential regulation of IL-10 release and proliferation of activated CD45RO+ and CD45RA+ PBL-T

IL-10 releaseProliferation
UnseparatedCD45RA+CD45RO+UnseparatedCD45RA+CD45RO+
Experiment 1
 Medium< Min< Min< Min6612446
 T112/3 + SRBC 702< Min136959 36116 47225 698
 T112/3 < Min< Min  11382357112
 OKT-3 + PBMO 13820 23444 45723 31331 403
 OKT-3 + IL-2 216< Min 47846 90823 51037 445
 PBMO  1920  18624165657
 OKT-3< Min< Min< Min38013562
Experiment 2
 Medium< Min< Min< Min495635
 T112/3+ SRBC1937< Min133366 7499 93729 736
 T112/3 < Min< Min< Min5621 17248
 OKT-3 + PBMO 16445 25737 83322 25938 923
 OKT-3 + IL-2 13212 13353 72053 93651 918
 PBMO  26< Min  231 0818282 145
Experiment 3
 Medium< Min< Min< Min395338
 T112/3+ SRBC1209< Min178630 0905 61315 197
 T112/3 < Min< Min< Min6982 832132
 OKT-3 + PBMO 28640 54650 94516 68150 745
 OKT-3 + IL-2 162< Min 29145 26513 79713 771
  • Unseparated and CD45RA+ and CD45RO+ PBL-T, respectively, were stimulated by CD2 monoclonal antibodies T112 and T113 (1/3000 v/v) in the presence or absence of SRBC (30 μl 5% SRBC for 106 cells), Sepharose bound CD3 monoclonal antibody OKT-3 (1/100 v/v) in the presence or absence of IL-2 (10 U/ml) or autologous irradiated (50 Gy) PBMO (30% of total cell number) and PBMO only. Supernatants were harvested after 60 hours and the IL-10 content of each (results expressed in pg/ml; detection limit (min) 10 pg/ml) was determined by using ELISA. Cell growth was measured by the incorporation of [3H]-thymidine after four days. Results are expressed as the mean cpm of triplicate cultures. SD < 20%.